Title: Magnetic assisted robotic surgery to facilitate reduced-port radical prostatectomy

Biography:

Jeffrey Cadeddu, M.D, is one of Texas leading urologists in the surgical treatment of prostate and kidney disorders. As Director of the UT Southwestern Clinical Center for Minimally Invasive Treatment of Urologic Cancer, he has performed more than 500 robotic/laparoscopic procedures on the prostate and introduced a number of firsts in the minimally invasive surgical treatment of kidney cancer and kidney disease.

Abstract

Robotic-assisted laparoscopic radical prostatectomy (RALP) is a well-accepted surgical treatment modality for localized prostate adenocarcinoma. Over the past decade, it has become the primary surgical treatment for prostate cancer in the United States and abroad. While more expensive than traditional open prostatectomy, it does confer less operative blood loss and shorter hospital stay at many institutions. Comparative prospective randomized data are lacking, but many studies have demonstrated that RALP confers at least equivalent oncological and functional outcomes compared to open. The surgical steps include peritoneal access, release of the bladder from anterior abdominal wall, ligation of the dorsal venous complex, dissection of the bladder neck and seminal vesicles, ligation of the vascular pedicles, transection of the urethra, and creation of a vesicourethral anastomosis. For patients with intermediate or high-risk prostate cancer, a pelvic lymph node dissection is also performed.